Literature DB >> 2901691

Structure/activity relations of N-methyl-D-aspartate receptor ligands as studied by their inhibition of [3H]D-2-amino-5-phosphonopentanoic acid binding in rat brain membranes.

H J Olverman1, A W Jones, K N Mewett, J C Watkins.   

Abstract

Structure/activity relations of agonists and antagonists for the N-methyl-D-aspartate receptor have been investigated by measuring the ability of a large range of substances to inhibit binding of [3H]2-amino-5-phosphonopentanoate to rat brain membranes. A major difference between optimum structures for agonist and antagonist activity lay in the differential effectiveness of sulphonic and phosphonic acid groups as the omega-acidic terminal in these two types of compound. The sulphonic acid moiety was an effective omega-acidic terminal in short chain agonists, but not in longer chain antagonists, while the phosphonic acid group was the most effective omega-acidic terminal in longer chain antagonists, but was only very weakly active in short chain agonists. It is proposed that the binding site of the omega-acidic terminal of antagonists is different from that for the omega-acidic group of agonists. Other structural features conducive to effective interaction of ligands with the receptor are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901691     DOI: 10.1016/0306-4522(88)90124-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

1.  Stationary gating of GluN1/GluN2B receptors in intact membrane patches.

Authors:  Stacy A Amico-Ruvio; Gabriela K Popescu
Journal:  Biophys J       Date:  2010-04-07       Impact factor: 4.033

2.  Physiological evidence that D-aspartate activates a current distinct from ionotropic glutamate receptor currents in Aplysia californica neurons.

Authors:  Stephen L Carlson; Lynne A Fieber
Journal:  J Neurophysiol       Date:  2011-07-13       Impact factor: 2.714

3.  Unique ionotropic receptors for D-aspartate are a target for serotonin-induced synaptic plasticity in Aplysia californica.

Authors:  Stephen L Carlson; Lynne A Fieber
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-04-09       Impact factor: 3.228

4.  Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine.

Authors:  D T Monaghan; H J Olverman; L Nguyen; J C Watkins; C W Cotman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.

Authors:  M Benveniste; M L Mayer
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

6.  Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine.

Authors:  M T Berhow; N Hiroi; E J Nestler
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

7.  S-sulfo-cysteine is an endogenous amino acid in neonatal rat brain but an unlikely mediator of cysteine neurotoxicity.

Authors:  Abdul-Karim Abbas; Wanlin Xia; Mattias Tranberg; Holger Wigström; Stephen G Weber; Mats Sandberg
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

8.  Anion transport blockers inhibit DL-2-amino-4-phosphonobutyrate responses induced by quisqualate in the rat cerebral cortex.

Authors:  J P Turner
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

9.  Functional N-methyl-D-aspartate receptors in clonal rat phaeochromocytoma cells.

Authors:  M Casado; A López-Guajardo; B Mellström; J R Naranjo; J Lerma
Journal:  J Physiol       Date:  1996-01-15       Impact factor: 5.182

10.  Dependence of single channel properties of the N-methyl-D-aspartate ion channel on stereoisomer agonists.

Authors:  J G McLarnon; D Sawyer
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.